Inventor · disambiguated record
Kenneth I. Kohn
Also filed as: KOHN KENNETH I
10 granted patents·10 pending applications·13 citations·filing 2013–2025
82Inventor score
Files withOPTIMDOSING LLC12EXCISION BIOTHERAPEUTICS INC3KAWAI TOSHIHISA2KARDIATONOS LLC1KOHN KENNETH I1
Top patents by PatentIndex Score
20 records- 0190US11491207B2Gene editing methods and compositions for eliminating risk of JC virus activation and PML (progressive multifocal leukoencephalopathy) during immunosuppressive therapyEXCISION BIOTHERAPEUTICS INC·Filed 2019·Granted Nov 8, 2022·7 cites·10 claims
- 0285US12009109B2Smart dosing for cancer therapyOPTIMDOSING LLC·Filed 2020·Granted Jun 11, 2024·2 cites·16 claims
- 0381US9867842B2Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damageKARDIATONOS LLC·Filed 2016·Granted Jan 16, 2018·2 cites·3 claims
- 0480US12205705B2Smart nutrition dosingOPTIMDOSING LLC·Filed 2021·Granted Jan 21, 2025·1 cites·14 claims
- 0574US2025062008A1Smart nutrition dosingOPTIMDOSING LLC·Filed 2024·Application pending·0 cites
- 0673US2024312641A1Smart dosing for cancer therapyOPTIMDOSING LLC·Filed 2024·Application pending·0 cites
- 0772US2023233654A1Gene editing methods and compositions for eliminating risk of jc virus activation and pml (progressive multifocal leukoencephalopathy) during immunosuppressive therapyEXCISION BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0871US2025232860A1Smart dosing for cancer therapyOPTIMDOSING LLC·Filed 2025·Application pending·0 cites
- 0966US12347538B2Smart multidosingOPTIMDOSING LLC·Filed 2020·Granted Jul 1, 2025·1 cites·8 claims
- 1065US2024233899A9Smart dosing for microbiome healthOPTIMDOSING LLC·Filed 2023·Application pending·0 cites
- 1164US12300370B2Smart dosing for cancer therapyOPTIMDOSING LLC·Filed 2021·Granted May 13, 2025·0 cites·19 claims
- 1263US2023420142A1Application for tracking progression and isolating causes of adverse medical conditionsOPTIMDOSING LLC·Filed 2023·Application pending·0 cites
- 1362US10279014B2Gene editing methods and compositions for eliminating risk of JC virus activation and PML (progressive multifocal leukoencephalopathy) during immunosuppressive therapyEXCISION BIOTHERAPEUTICS INC·Filed 2018·Granted May 7, 2019·0 cites·11 claims
- 1456US9925204B2Anti-inflammatory compounds in combination with hydrogen for the treatment of inflammationKAWAI TOSHIHISA·Filed 2016·Granted Mar 27, 2018·0 cites·20 claims
- 1555US9545415B2Anti-inflammatory compounds in combination with hydrogen for the treatment of inflammationSKYVIEW ENTPR LTD·Filed 2013·Granted Jan 17, 2017·0 cites·18 claims
- 1647US2015335615A1Cholesterol-lowering compounds in combination with lipid metabolism-altering compounds of non-absorbable sugars, compounds that convert nh3 to nh4+, or hydrogen-generating compounds for the treatment of high cholesterol and inflammationKAWAI TOSHIHISA·Filed 2014·Application pending·0 cites
- 1746US12293815B2Smart multidosingOPTIMDOSING LLC·Filed 2021·Granted May 6, 2025·0 cites·15 claims
- 1841US2021375485A1Application for tracking infectious diseaseOPTIMDOSING LLC·Filed 2021·Application pending·0 cites
- 1940US2017056504A1Method of extending half-life of crystaline antibodiesKOHN KENNETH I·Filed 2016·Application pending·0 cites
- 2039US2022336109A1Application for tracking progression and isolating causes of adverse medical conditionsOPTIMDOSING LLC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →